There are conflicting reports about the timeline for a potential coronavirus vaccine, but new reports indicate Pfizer could learn whether its vaccine is effective by the end of October.
The vaccine testing is currently in Phase 3 and there is a “60 percent” chance that the vaccine results will be made available.
“We have already manufactured hundreds of thousands of doses, so just in case we have a good study readout, conclusive, and FDA plus the advisory committee feels comfortable, that we will be ready,” Bourla told CBS’s Face the Nation.
There are currently 35 potential coronavirus vaccines that are in different stages of testing.
The coronavirus mainly comes from animals and a majority of those who were infected early either worked at or frequently visited the Huanan seafood wholesale market in Wuhan, according to The Guardian. The virus is similar to Severe acute respiratory syndrome (Sars) and Middle Eastern respiratory syndrome (Mers).
The Wuhan coronavirus is transmitted from person to person through “droplet transmission.” That means an infected person can pass the virus by sneezing or coughing on another person as well as by direct contact.
While a majority of the cases have been detected in the United States and China — with more than 6.38 million confirmed cases and 191,000 deaths in the United States — it has now reached many countries around the world. It has also been confirmed in Italy, Australia, Canada, France, Germany, and many other eastern countries.